首页> 外文期刊>Protein Expression and Purification >Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization
【24h】

Engineering of the Saccharomyces cerevisiae yeast strain with multiple chromosome-integrated genes of human alpha-fetoprotein and its high-yield secretory production, purification, structural and functional characterization

机译:具有人类α-甲胎蛋白的多个染色体整合基因的酿酒酵母酵母菌株的工程设计及其高产分泌产生,纯化,结构和功能表征

获取原文
获取原文并翻译 | 示例
       

摘要

Alpha-fetoprotein (AFP) is a biological drug candidate of high medicinal potential in the treatment of autoimmune diseases, cancer, and regenerative medicine. Large-scale production of recombinant human alpha-fetoprotein (rhAFP) is desirable for structural and functional studies and applied research. In this study we cloned and expressed in the secreted form wild-type glycosylated human rhAFP and non-glycosylated mutant rhAFP _0 (N233S) in the yeast strain Saccharomyces cerevisiae with multiple chromosome-integrated synthetic human AFP genes. RhAFP and rhAFP _0 were successfully produced and purified from the culture liquids active naturally folded proteins. Elimination of the glycosylation by mutation reduced rhAFP _0 secretion about threefold as compared to the wild-type protein showing critical role of the N-linked glycan for heterologous protein folding and secretion. Structural similarity of rhAFP and rhAFP _0 with natural embryonic eAFP was confirmed by circular dichroism technique. Functional tests demonstrated similar type of tumor suppressive and immunosuppressive activity for both recombinant species rhAFP and rhAFP _0 as compared to natural eAFP. It was documented that both types of biological activities attributed to rhAFP and rhAFP _0 are due to the fast induction of apoptosis in tumor cells and mitogen-activated lymphocytes. Despite the fact that rhAFP and rhAFP _0 demonstrated slightly less effective tumor suppressive activity as compared to eAFP but rhAFP _0 had produced statistically notable increase in its ability to induce inhibition of in vitro lymphocyte proliferation as compared to the glycosylated rhAFP and eAFP. We conclude that N-linked glycosylation of rhAFP is required for efficient folding and secretion. However the presence of N-linked sugar moiety was shown to be unimportant for tumor suppressive activity but was critically important for its immunoregulative activity which demonstrates that different molecular mechanisms are involved in these two types of biological functional activities attributed to AFP.
机译:甲胎蛋白(AFP)是在治疗自身免疫性疾病,癌症和再生医学方面具有较高医学潜力的生物药物候选物。重组人甲胎蛋白(rhAFP)的大规模生产对于结构和功能研究以及应用研究是理想的。在这项研究中,我们在酵母菌株酿酒酵母中克隆并以分泌形式表达了野生型糖基化人rhAFP和非糖基化突变体rhAFP _0(N233S),并整合了多个染色体,合成了人AFP基因。 RhAFP和rhAFP _0已成功生产并从培养液中天然折叠的活性蛋白质中纯化。与野生型蛋白相比,通过突变消除糖基化将rhAFP_0分泌减少了约三倍,这表明N-连接聚糖对异源蛋白折叠和分泌起着关键作用。通过圆二色性技术证实了rhAFP和rhAFP _0与天然胚胎eAFP的结构相似性。功能测试表明,与天然eAFP相比,重组物种rhAFP和rhAFP _0的肿瘤抑制和免疫抑制活性类型相似。据报道,归因于rhAFP和rhAFP_0的两种类型的生物活性均归因于肿瘤细胞和促有丝分裂原活化的淋巴细胞中细胞凋亡的快速诱导。尽管事实是,rhAFP和rhAFP _0与eAFP相比显示出稍低的有效肿瘤抑制活性,但与糖基化rhAFP和eAFP相比,rhAFP _0在诱导体外淋巴细胞增殖的抑制能力上产生了统计学上显着的提高。我们得出结论,rhAFP的N联糖基化是有效折叠和分泌所必需的。然而,显示N-连接的糖部分对于肿瘤抑制活性并不重要,但对其免疫调节活性至关重要,这表明归因于AFP的这两种类型的生物学功能活性涉及不同的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号